604 results on '"Yokoyama, Masahiro"'
Search Results
2. Millennial-scale paleotemperature change in the Japan Sea during Marine Isotope Stage 3: Impact of meridional oscillation of the subpolar front
3. A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
4. Measurement of full-scale phase change material products considering hysteresis
5. Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL
6. MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era
7. The clonal evolution during long-term clinical course of multiple myeloma
8. Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient
9. Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort study
10. Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)
11. Safe Trans Loader: Mitigation and Prevention of Memory Corruption Attacks for Released Binaries
12. Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis
13. Estimation of Lifetime Distribution with Covariates Using Online Monitoring
14. BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation
15. Obesity and Mild Hyperinsulinemia Found in Neuropeptide Y-Y1 Receptor-Deficient Mice
16. Impact of chitin-derived β-N-acetyl-d-glucosaminyl-(1,4)-d-glucosamine on chitinase upregulation in Shewanella baltica.
17. Supplementary Data from An Imaging-Based Rapid Evaluation Method for Complement-Dependent Cytotoxicity Discriminated Clinical Response to Rituximab-Containing Chemotherapy
18. Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance
19. Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan
20. Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies
21. Safe Trans Loader: Mitigation and Prevention of Memory Corruption Attacks for Released Binaries
22. Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results
23. O1-15-1 - Azacytidine is effective in the therapy related myelodysplastic syndrome
24. Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation
25. Hepatic toxicity and prognosis in hepatitis C virus–infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis
26. Millennial-Scale Paleotemperature Change in the Japan Sea During Marine Isotope Stage 3: Impact of Meridional Oscillation of the Subpolar Front
27. Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents
28. Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer
29. Diffuse large B‐cell lymphoma arising immediately after completion of treatment for Hodgkin lymphoma
30. Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas
31. Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkinʼs lymphoma or systemic anaplastic large-cell lymphoma
32. Rapid Progression of Anemia Related to Tumor-lysis Syndrome Associated with Bortezomib Treatment in Myeloma Patients
33. Additional file 1 of Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)
34. Thermal Proteome Profiling Reveals Glutathione Peroxidase 4 as the Target of the Autophagy Inducer Conophylline
35. Increased incidence of interstitial pneumonia by CHOP combined with rituximab
36. Myelomatous meningitis: a case report
37. Gastric involvement, a rare site for extramedullary myeloma
38. Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma
39. Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population
40. Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
41. Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma
42. Prognostic Value of C-reactive Protein, Lactase Dehydrogenase and Anemia in Recurrent or Refractory Aggressive Lymphoma
43. Prognostic Impact of Extranodal Involvement in Diffuse Large B-Cell Lymphoma in the Rituximab Era
44. Feasibility and Efficacy of Combined Cisplatin and Irinotecan Chemotherapy for Poorly Differentiated Neuroendocrine Carcinomas
45. Safety, Efficacy and Pharmacokinetics of Neratinib (HKI-272) in Japanese Patients with Advanced Solid Tumors: A Phase 1 Dose-escalation Study
46. Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era
47. Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study
48. The clonal evolution during long-term clinical course of multiple myeloma
49. Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
50. 【論文】技能競技大会出場選手の技能向上メカニズム解明への探索的研究-ものづくり技能に影響を与える要因の収集
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.